Comparing two gels for moderate acne
Part of Skin clinical trials.
This study tests if metronidazole gel or clindamycin gel works better for people with moderate acne. It aims to find a good treatment option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 35 years old.
- You must have moderate acne (not too mild or too severe).
- You must not be using any other acne treatments right now.
- You must not be pregnant or breastfeeding.
- You must not be allergic to metronidazole or clindamycin.
- You must not have any other face skin condition that could affect the acne assessment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This trial tests a new acne cream called clascoterone compared to a standard cream, adapalene, for mild acne. It aims to see which one works better for clearing pimples.
This trial tests a cream called clascoterone (1%) for people ages 12 and up with moderate to severe facial acne. The cream is applied daily to help reduce pimples and clogged pores.
This trial compares a gel containing adapalene (a retinoid) plus hyaluronic acid (a moisturizer) to adapalene gel alone for mild to moderate acne. It aims to see if adding hyaluronic acid helps reduce irritation and improve results.
This study compares a new dutasteride gel to a standard acne triple-combination gel for treating facial acne in adults. It aims to find a more effective topical treatment.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.